These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 1592230)

  • 41. Adenosine and AICA-riboside fail to enhance microvascular endothelial preservation.
    Sellke FW; Friedman M; Wang SY; Piana RN; Dai HB; Johnson RG
    Ann Thorac Surg; 1994 Jul; 58(1):200-6. PubMed ID: 8037525
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Optimal potassium concentration in cardioplegic solutions].
    Yu G; Ye D
    Zhonghua Xin Xue Guan Bing Za Zhi; 1990 Feb; 18(1):42-6, 62. PubMed ID: 2397698
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effect of crystalloid cardioplegia and verapamil on cardiac function and cellular biochemistry during hypothermic cardiac arrest.
    Prasad K; Bharadwaj B
    Can J Cardiol; 1987 Sep; 3(6):293-9. PubMed ID: 2962703
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Mitochondrial role in ischemia-reperfusion of rat hearts exposed to high-K+ cardioplegia and clonazepam: energetic and contractile consequences.
    Consolini AE; Ragone MI; Conforti P; Volonté MG
    Can J Physiol Pharmacol; 2007 May; 85(5):483-96. PubMed ID: 17632582
    [TBL] [Abstract][Full Text] [Related]  

  • 45. High cardioplegic perfusion pressure entails reduced myocardial recovery.
    Irtun O; Sørlie D
    Eur J Cardiothorac Surg; 1997 Feb; 11(2):358-62. PubMed ID: 9080168
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Enflurane and isoflurane, but not halothane, protect against myocardial reperfusion injury after cardioplegic arrest with HTK solution in the isolated rat heart.
    Preckel B; Schlack W; Thämer V
    Anesth Analg; 1998 Dec; 87(6):1221-7. PubMed ID: 9842801
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The myocardial protective effects of a moderate-potassium adenosine-lidocaine cardioplegia in pediatric cardiac surgery.
    Jin ZX; Zhang SL; Wang XM; Bi SH; Xin M; Zhou JJ; Cui Q; Duan WX; Wang HB; Yi DH
    J Thorac Cardiovasc Surg; 2008 Dec; 136(6):1450-5. PubMed ID: 19114188
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Enhanced myocardial protection with adenosine.
    Bolling SF; Bies LE; Gallagher KP; Bove EL
    Ann Thorac Surg; 1989 Jun; 47(6):809-15. PubMed ID: 2757434
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Age-related changes in the ability of hypothermia and cardioplegia to protect ischemic rabbit myocardium.
    Baker JE; Boerboom LE; Olinger GN
    J Thorac Cardiovasc Surg; 1988 Nov; 96(5):717-24. PubMed ID: 3184966
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Comparison of enoximone, amrinone, or levosimendan enriched St. Thomas' hospital cardioplegic solutions used for myocardial preservation in isolated guinea pig hearts.
    Köksal C; Süzer O; Bozkurt AK; Köseoğlu S
    Acta Medica (Hradec Kralove); 2002; 45(3):93-7. PubMed ID: 12515045
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Superiority of hyperpolarizing to depolarizing cardioplegia in protection of coronary endothelial function.
    He GW; Yang CQ
    J Thorac Cardiovasc Surg; 1997 Oct; 114(4):643-50. PubMed ID: 9338651
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Advantages of continuous hyperpolarized arrest with pinacidil over St. Thomas' Hospital solution during prolonged ischemia.
    Jayawant M; Stephenson ER; Damiano RJ
    J Thorac Cardiovasc Surg; 1998 Jul; 116(1):131-8. PubMed ID: 9671907
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cardioprotection with esmolol cardioplegia: efficacy as a blood-based solution.
    Fujii M; Chambers DJ
    Eur J Cardiothorac Surg; 2013 Mar; 43(3):619-27. PubMed ID: 22715477
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Improvement of cardiac function impaired by repeated ischemic arrests in isolated rat hearts.
    Ali K; Morimoto M; Fukaya Y; Furukawa Y
    Ann Thorac Surg; 1993 Apr; 55(4):902-7. PubMed ID: 8466346
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Oxygenation of cardioplegic solutions. Potential for the calcium paradox.
    Hendren WG; Geffin GA; Love TR; Titus JS; Redonnett BE; O'Keefe DD; Daggett WM
    J Thorac Cardiovasc Surg; 1987 Oct; 94(4):614-25. PubMed ID: 3116349
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effects of supplemental L-arginine during warm blood cardioplegia.
    Hayashida N; Tomoeda H; Oda T; Tayama E; Chihara S; Akasu K; Kosuga T; Kai E; Aoyagi S
    Ann Thorac Cardiovasc Surg; 2000 Feb; 6(1):27-33. PubMed ID: 10748356
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Outcome and complications of intraoperative hemodialysis during cardiopulmonary bypass with potassium-rich cardioplegia.
    Khoo MS; Braden GL; Deaton D; Owen S; Germain M; O'Shea M; Mulhern J; Rousou J; Flack J; Engleman R
    Am J Kidney Dis; 2003 Jun; 41(6):1247-56. PubMed ID: 12776278
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Zinc supplementation enhances the effectiveness of St. Thomas' Hospital No. 2 cardioplegic solution in an in vitro model of hypothermic cardiac arrest.
    Powell SR; Aiuto L; Hall D; Tortolani AJ
    J Thorac Cardiovasc Surg; 1995 Dec; 110(6):1642-8. PubMed ID: 8523874
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Beyond hyperkalemia: beta-blocker-induced cardiac arrest for normothermic cardiac operations.
    Ede M; Ye J; Gregorash L; Summers R; Pargaonkar S; LeHouerou D; Lessana A; Salerno TA; Deslauriers R
    Ann Thorac Surg; 1997 Mar; 63(3):721-7. PubMed ID: 9066391
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Myocardial protection in the acutely injured heart: hyperpolarizing versus depolarizing hypothermic cardioplegia.
    Lawton JS; Hsia PW; Allen CT; Damiano RJ
    J Thorac Cardiovasc Surg; 1997 Mar; 113(3):567-75. PubMed ID: 9081104
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.